PROF
NASDAQ HealthcareProfound Medical Corp. - common stock
Medical Devices
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. It operates in Canada, Germany, the United States, China, and Finland. Profound Medical Corp. is headquartered in Mississauga, Canada.
�� 市场数据
| 价格 | $6.65 |
|---|---|
| 成交量 | 117,893 |
| 市值 | 241.35M |
| 贝塔系数 | 0.470 |
| RSI（14日） | 58.8 |
| 200日均线 | $6.15 |
| 50日均线 | $6.35 |
| 52周最高 | $8.95 |
| 52周最低 | $3.76 |
| Forward P/E | -8.48 |
| Price / Book | 3.63 |
🎯 投资策略评分
PROF 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🔪 Falling Knife (65/100) — 此策略 逆向投资（超卖 + 低于移动均线）.
评分最低的策略： 🐋 Institutional Whale (5/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 PROF in your text
粘贴任何文章、记录或帖子 — 工具将提取 PROF 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-04-17.